Epirubicin plus tamoxifen versus tamoxifen alone in node-positive postmenopausal patients with breast cancer: A randomized trial of the International Collaborative Cancer Group.

Source:http://linkedlifedata.com/resource/pubmed/id/10561249

Download in:

View as

General Info

PMID
10561249